Average Co-Inventor Count = 5.16
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Biomarin Pharmaceutical Inc. (7 from 136 patents)
7 patents:
1. 12514906 - Use of C-Type Natriuretic Peptide Variants to Treat Skeletal Dysplasia
2. 12076372 - Use of C-type natriuretic peptide variants to treat skeletal dysplasia
3. 11911446 - Use of C-type natriuretic peptide variants to treat skeletal dysplasia
4. 11590204 - Use of C-type natriuretic peptide variants to treat skeletal dysplasia
5. 10646550 - Use of C-type natriuretic peptide variants to treat skeletal dysplasia
6. 9907834 - Use of C-type natriuretic peptide variants to treat skeletal dysplasia
7. 9216178 - Dry blend formulation of tetrahydrobiopterin